medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2010, Number 1

<< Back Next >>

Arch Neurocien 2010; 15 (1)

Frecuency of neurocysticercosis at the high specialty regional hospital ciudad salud of Tapachula, Chiapas, Mexico

Canseco-Ávila LM, Sánchez-González RA, Salgado-Camacho JM, Espinosa-Ruiz M, Domínguez-Arrevillaga S

Language: Spanish
References: 21
Page: 4-7
PDF size: 95.08 Kb.


ABSTRACT

Neurocysticercosis (NCC) is the most common infection of the human nervous system by the larval stage of the tapeworm taenia solium. It is the most common helminthic infection of the nervous system and is endemic in Latin America (including Mexico), Asia and Africa, as well as in industrialized nations with a high immigrant influx of people coming from endemic areas. It is a public health problem. The diagnosis is not possible on clinical grounds, it is necessary the practice of complementary tests in every suspected case, since the diagnosis require proper interpretation of clinical, neuroimaging, and serologic data, in the correct epidemiological context Chiapas have been reported to have a high prevalence of NCC which makes it a health issue for the State, for this reason it is important to monitor, diagnose and treat this disease. The aim of this study was to determine the prevalence of NCC in a patient population from the Hospital in Tapachula, Chiapas. A descriptive and retrospective analysis was made through revision of archived clinical records during the period of March 2006 to April 2009. A total of 638 patients were referred to the neurology service, of which 13 were diagnosed with NCC, representing a prevalence of 2.03%, which is considerably low compared with other reported studies in Mexico. It is important to strengthen ties with the first and second levels of care for a proper diagnosis of NCC.


REFERENCES

  1. Villalobos Perozo R. Manifestaciones clínicas de presentación de neurocisiticercosis. Kasmera 2003; 31(2): 80-5.

  2. Flisser A, Madrazo I, Delgado H. Cisticercosis humana. México D.F. El Manual Moderno; 1997.

  3. García HH, del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am 2000; 14(1):97-119.

  4. Organización Panamericana de la Salud. Epidemiología y control de la teniosis y cisticercosis en América Latina. Washington DC. OPS/ OMS. 1994: 25.

  5. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002; 2(12):751-62.

  6. Álvarez Rodríguez E, Torres Gárate R, Gutiérrez Larráinzar A, Cabello J, Espinós Pérez D. Neurocisticercosis: recomendaciones de tratamiento a propósito de tres casos. An Med Interna 2004; 21(8): 24-8.

  7. Estebán Morales A, Quiroz Cabrera JM, Salazar Zuñiga A. Neurocisticercosis: prevalencia en el Hospital Central Militar. Rev Sanit Milit Mex 2002; 56(1): 15-22.

  8. Del Bruto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57(2):177-83.

  9. Singh P, Singhi S. Neurocysticercosis in children. J Clin Neurol 2004;19: 482-92.

  10. Alarcón F. Neurocisticercosis: etiopatogenia, manifestaciones clínicas, diagnóstico y tratamiento. Rev Neurol 2006;43s1:93-100.

  11. Sotelo J. Cysticercosis. En: Current therapy in neurologic diseases. Ed. Decker incorporated 1987: 114-7.

  12. Aguilar RF. Perfil de la neurocisticercosis en niños mexicanos. Cir Ciruj 1998; 66(3):89-98.

  13. Navarro MCA. Cisticercosis cerebral como causa de convulsiones en el puerperio. Rev San Mil 1989: 43(5): 207-10.

  14. Flisser A, Malagon F. Cisticercosis humana y porcina su conocimiento e investigación en México. Ed. Limusa, 1989:233-66.

  15. Flisser A, Gyorkos TW. Contribution of immunodiagnostic tests to epidemiological/intervention studies of cysticercosis/taeniosis in México. Parasite Immunol 2007: 29(12): 637-49.

  16. Rodríguez Leyva I, Juárez Sanjuan A, Cuevas E. Neurocisticercosis en un hospital general de San Luis Potosí, México. Rev Ecuat Neurol 2000: 9(3).

  17. Solís Quispe AM, Tello Chumpitaz TJ, Quinte Sarmiento DH, Ramírez Flores SE. Prevalencia y factores de riesgo asociados a neurocisticercosis trabajadores del camal Conchucos, El Agustino, Perú. Acta Med Per 2007: 24(3): 167-71.

  18. Schantz P M. Cysticercosis in non-endemic countries: the example of the United State; in taeniasis/cysticercosis. Ed. Universe S.A. 1996: 277-86.

  19. Más Sesé G, Vives Piñera I, Fernández Barreiro A, Martínez Lage JF, Martínez Salcedo E, Alarcón Martínez H, et. al. Estudio descriptivo de neurocisticercosis en un hospital terciario. Rev Neurol 2008; 46 (4): 194-6.

  20. Ortíz Trejo JM, Correa Chacón AJ, Sotelo Ham EI, Torres Valenzuela A, Alvarado Esquivel C. Factores de riesgo asociados a neurocisticercosis en un hospital público de México. Gac Méd Méx 2006: 142 (3): 175-9.

  21. Nath Prasad K, Prasad A, Verma A, Kumar Singh A. Human cysticercosis and Indian scenario: a review. J Biosci 2008:33 (4):571-82.




2020     |     www.medigraphic.com